More on BAYRY
Data
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $13.60 |
|
|||
| Open | $13.60 | ||||
| 52 Wk High | $135.54 | ||||
| 52 Wk Low | $94.36 | ||||
| Day High | $13.60 | ||||
| Day Low | $13.60 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 6,755 | ||||
- Bayer and Henry Ford Health Announce Strategic Research Partnership to Expand Patient Access to Clinical Trials
- Sabanto and Leaps by Bayer Announce Oversubscribed Series B Financing to Scale Autonomous Technology for Row Crop Farming
- Bayer AG (BAYN:GR) (BAYRY) PT Raised to EUR60 at Barclays
- Bayer AG (BAYN:GR) (BAYRY) PT Raised to EUR65 at Morgan Stanley
- Bayer AG (BAYN:GR) (BAYRY) PT Raised to EUR55 at Berenberg
- The University of Colorado Anschutz, along with UCHealth and Children’s Hospital Colorado, Form Strategic Alliance with Bayer to Advance Drug Development and Clinical Trials
- Bayer AG (BAYN:GR) (BAYRY) PT Raised to EUR62.50 at Goldman Sachs
- Luke Bryan and One A Day® Launch Limited Edition Multivitamin Bottles Available Only at Walmart
- Deutsche Bank Upgrades Bayer AG (BAYN:GR) (BAYRY) to Buy
- Bayer Group to Consolidate U.S. Glyphosate Business Into Distinct Entity Operating as Ruveon
Entities mentioned with BAYRY
- Twitter | View Related Stories »
- FDA | View Related Stories »
- Definitive Agreement | View Related Stories »
- Earnings | View Related Stories »
- ARK | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- Maynard Um | View Related Stories »
- Credit Suisse | View Related Stories »
- Show More...
